Science

Long-term follow-up of psilocybin-facilitated smoking cessation

A recent open-label pilot study (N = 15) found that two to three moderate to high doses (20 and 30 mg/70 kg) of the serotonin 2A receptor agonist, psilocybin, in combination with cognitive behavioral therapy (CBT) for smoking cessation, resulted in substantially higher 6-month smoking abstinence rates than are typically observed with other medications or CBT alone.

Conclusion: These results suggest that in the context of a structured treatment program, psilocybin holds considerable promise in promoting long-term smoking abstinence. The present study adds to recent and historical evidence suggesting high success rates when using classic psychedelics in the treatment of addiction. Further research investigating psilocybin-facilitated treatment of substance use disorders is warranted.

Original Article (Tandfoline):
Long-term follow-up of psilocybin-facilitated smoking cessation
Artwork Fair Use: Lindsay Fox

What is kratom…?

Kratom LD-50 Stats

Science

Change, grow, live

Rolling in the deep

The Peace Drug

Leave a Reply